CLINICAL_TRIALS
trial_result
· 2026-02-04
Clinical Trial Update: Tazemetostat in Malignant Peripheral Nerve Sheath Tumors [Phase 2]
Summary
Phase 2 trial results for tazemetostat in malignant peripheral nerve sheath tumors have been posted, and the study is currently not recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Florida | Conditions: Peripheral Nerve Sheath Tumor | Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2026-02-04